Dr. Diana Horvath’s interests are in the delivery of seed with improved disease resistance, particularly to improve harvests for smallholder farmers. Before joining Roger Freedman to set up 2Blades, she served as Science Director at ATP Capital, a New York venture capital firm that invested in companies developing agricultural biotechnologies. Focusing on technology and intellectual property, she helped to build and manage a portfolio of companies involved in forestry biotechnology, transcriptome and proteome analysis, small molecule discovery, and embryonic stem cells. Prior to that, Dr. Horvath conducted research on the molecular mechanisms of plant disease resistance as a National Science Foundation fellow and Zeneca Plant Science fellow at the Rockefeller University. Dr. Horvath received her Ph.D. in biochemistry and molecular biology from Northwestern University. She spent a year conducting research on maize and millet production in southern Africa at the Department of Agricultural Research in Botswana, after graduating from Tufts University with a BS in Biology.